Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeted therapy: wave of the future.
Pegram MD, Pietras R, Bajamonde A, Klein P, Fyfe G. Pegram MD, et al. Among authors: bajamonde a. J Clin Oncol. 2005 Mar 10;23(8):1776-81. doi: 10.1200/JCO.2005.11.029. J Clin Oncol. 2005. PMID: 15755985 Review. No abstract available.
Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab.
Dybdal N, Leiberman G, Anderson S, McCune B, Bajamonde A, Cohen RL, Mass RD, Sanders C, Press MF. Dybdal N, et al. Among authors: bajamonde a. Breast Cancer Res Treat. 2005 Sep;93(1):3-11. doi: 10.1007/s10549-004-6275-8. Breast Cancer Res Treat. 2005. PMID: 16184453
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER; VIVA Investigators. Henry TD, et al. Among authors: bajamonde a. Circulation. 2003 Mar 18;107(10):1359-65. doi: 10.1161/01.cir.0000061911.47710.8a. Circulation. 2003. PMID: 12642354 Clinical Trial.